Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
Arow, M., Waldman, M., Yadin, D., Nudelman, V., Shainberg, A., Abraham, N. G., Freimark, D., Kornowski, R., Aravot, D., Hochhauser, E., Arad, M.Volume:
19
Language:
english
Journal:
Cardiovascular Diabetology
DOI:
10.1186/s12933-019-0980-4
Date:
December, 2020
File:
PDF, 2.12 MB
english, 2020